![Notice to Extend the Expiration Date of PA-24-248 PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)](https://resilienceengineeringinstitute.org/wp-content/uploads/2018/01/NIH-logo-v2.jpg){kind=logo}
RSS feed source: National Institute of Health
Notice to Extend the Expiration Date of PA-24-248 PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
The purpose of this notice is to Extend the Expiration Date of PA-24-248 PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) by one receipt date. PA-24-248 will now expire on September 6, 2025.
Due to the extension, the following dates will be added:
Standard application due date : September 5, 2025
Scientific Merit Review: November 2025
Advisory Council: January 2026
The following sections of the FOA have been changed:
Part 1. Overview Information, Key Dates
Currently reads:
Application Due DatesReview and Award CyclesNewRenewal / Resubmission / Revision (as allowed)AIDS – New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start DateSeptember 05, 2024 *September 05, 2024 *Not
Click this link to continue reading the article on the source website.
RSS feed source: National Institute of Health
Notice to Extend the Expiration Date of PA-24-247 PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
The purpose of this notice is to extend the expiration date of PA-24-247 PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) by one receipt date. PA-24-247 will now expire on September 6, 2025.
Due to the extension, the following dates will be added:
Standard application due date : September 5, 2025
Scientific Merit Review: November 2025
Advisory Council: January 2026
The following sections of the FOA have been changed:
Part 1. Overview Information, Key Dates
Currently reads:
Application Due DatesReview and Award CyclesNewRenewal / Resubmission / Revision (as allowed)AIDS – New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start DateSeptember 05, 2024 *September 05,
Click this link to continue reading the article on the source website.
RSS feed source: National Institute of Health
Notice to Extend the Expiration Date of PA-24-246 PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
The purpose of this notice is to extend the expiration date of PA-24-246 PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) by one receipt date. PA-24-246 will now expire on September 6, 2025.
Due to the extension, the following dates will be added:
Standard application due date : September 5, 2025
Scientific Merit Review: November 2025
Advisory Council: January 2026
The following sections of the FOA have been changed:
Part 1. Overview Information, Key Dates
Currently reads:
Application Due DatesReview and Award CyclesNewRenewal / Resubmission / Revision (as allowed)AIDS – New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start DateSeptember 05, 2024
Click this link to continue reading the article on the source website.
RSS feed source: National Institute of Health
Notice to Extend the Expiration Date of PA-24-245 PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
The purpose of this notice is to extend the expiration date of PA-24-245 PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) by one receipt date. PA-24-245 will now expire on September 6, 2025.
Due to the extension, the following dates will be added:
Standard application due date : September 5, 2025
Scientific Merit Review: November 2025
Advisory Council: January 2026
The following sections of the NOFO have been changed:
Part 1. Overview Information, Key Dates
Currently reads:
Application Due DatesReview and Award CyclesNewRenewal / Resubmission / Revision (as allowed)AIDS – New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest
Click this link to continue reading the article on the source website.